Repeat Late GDM Testing and Cesarean Delivery Rates
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorShauna F. Williams, MD
About this trial
The goal of this randomized trial is determine if re-testing for gestational diabetes in the third trimester after an ultrasound measurement of estimated fetal weight (EFW) or abdominal circumference greater than 90%ile decreases cesarean delivery rate, and to evaluate the optimal method of re-testing. The main question it aims to answer is:
Does repeat testing for gestational diabetes and management of hyperglycemia decrease the cesarean delivery rate in fetuses measuring \>90%ile by estimated fetal weight (EFW) or abdominal circumference (AC) on ultrasound in the third trimester.
Participants will be randomized into two groups: Group 1 will undergo a repeat glucose tolerance test (GTT) with blinded continuous glucose monitor (CGM) and group 2 will have no intervention. Participants in group 1 will receive nutrition counseling as this would be standard in patients at high risk for gestational diabetes.
Eligibility criteria
Qualifiers
Gestational age 30 weeks 0 days and 36 weeks 6 days
Ultrasound with estimated fetal weight or abdominal circumference greater than 90th%ile
Age 18-50 years old.
Disqualifiers
Previously diagnosed gestational diabetes or pre-gestational diabetes
Multiple gestation
Previous cesarean delivery
Any condition precluding vaginal delivery (placenta previa/placenta accreta spectrum disorders, vasa previa, prior uterine surgery with contraindication to vaginal delivery)
Trial design
Treatments tested in this trial
- Glucose tolerance test and continuous glucose monitor
Treatment groups
144 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Shauna F. Williams, MD
Lead sponsor
Rutgers, The State University of New Jersey
Sponsor institution
Source ClinicalTrials.gov